Related Experiment Video
Updated: Aug 8, 2026

Isolation, Expansion, and Adipogenic Induction of CD34+CD31+ Endothelial Cells from Human Omental and Subcutaneous Adipose Tissue
Published on: July 17, 2018
20-Hydroxyeicosatetraenoic acid is not associated with circulating insulin in lean to overweight humans
Natalie C Ward1, Jonathan M Hodgson, Ian B Puddey
1School of Medicine & Pharmacology RPH, University of Western Australia, Level 4, Rear 50 Murray Street, Perth, WA 6000, Australia. nward@cyllene.uwa.edu.au <nward@cyllene.uwa.edu.au>
Abstract:
Hypertension is often associated with insulin resistance or hyperinsulinemia. Metabolism of arachidonic acid by cytochrome P450 to the vasoconstrictor 20-HETE is thought to be involved in the pathogenesis of hypertension, but the relationship of 20-HETE with insulin resistance is not clearly understood. Obesity is a major determinant of insulin resistance, and we have previously demonstrated a positive relationship between BMI and 20-HETE in untreated hypertensive and normotensive individuals. The present analysis sought to determine if this relationship was related to insulin levels or insulin resistance (HOMA). We analysed 24h urinary excretion of 20-HETE, serum insulin levels and insulin resistance in 66 lean to overweight untreated hypertensive and normotensive individuals. There was a significant positive association between 20-HETE and BMI (p<0.001), and serum insulin and BMI (p=0.003). There were no associations between 20-HETE excretion and either serum insulin or insulin resistance, before or after adjustment for age, gender, BMI and BP, or when hypertensive and normotensive individuals were considered separately. The results of the present study suggest that the observed positive association between urinary 20-HETE excretion and BMI may not be related to circulating insulin levels or insulin resistance.
Related Concept Videos
Obesity
Insulin: Dosing Regimen and Adverse Effects
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
Type II Diabetes I: Introduction
Type II Diabetes II: Pathophysiology
Insulin: The Receptor and Signaling Pathways
Diabetes Mellitus: Type 2 and Gestational
